<strong>Care</strong> <strong>and</strong> <strong>support</strong> <strong>for</strong> <strong>people</strong> <strong>living</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong>Box 16. Strengthening “horizontal” collaboration on <strong>HIV</strong> <strong>and</strong> sexuallytransmitted infections in Latin America <strong>and</strong> the CaribbeanBuilding on a long tradition of joint collaboration in the region, <strong>and</strong> the desire <strong>for</strong>more self-reliance <strong>and</strong> less dependency on donors, the Directors of national <strong>AIDS</strong>programmes from 12 countries agreed in 1996 to set up a new process <strong>for</strong> “horizontal”interregional technical cooperation. As part of the reciprocal process ofexchanging experience, in<strong>for</strong>mation <strong>and</strong> technology on equal terms, <strong>for</strong> example, theHorizontal Technical Collaboration Group (HTCG) has encouraged intercountry visitsso that members can see first-h<strong>and</strong> how to improve drug management <strong>and</strong> distributionin rural areas. Through a multicountry survey conducted by the Group on theprices being paid <strong>for</strong> <strong>HIV</strong>-related drugs <strong>and</strong> commodities, countries became awareof major price differences <strong>and</strong> were in a better position to negotiate price reductions<strong>with</strong> pharmaceutical companies. Argentina, <strong>for</strong> instance, was able to reduce the costof measuring viral load from US$ 250 to US$ 70. The HTCG also provided the initialimpetus <strong>for</strong> establishing a revolving fund <strong>for</strong> <strong>HIV</strong>-related drugs under the auspices ofthe Pan American Health Organization, WHO’s Regional Office <strong>for</strong> the Americas. Thefund is now in its initial trial phase.As of May 1999, 21 countries belonged to the HTCG* <strong>and</strong> ef<strong>for</strong>ts are now under wayto incorporate national <strong>AIDS</strong> programme Directors from Central America <strong>and</strong> fromthe English-, Dutch- <strong>and</strong> French-speaking countries in the Caribbean.* Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador,Guatemala, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay <strong>and</strong> Venezuela.Comprehensive care <strong>and</strong> <strong>support</strong> strategy neededIn the early 1990s, WHO’s Global Programme on <strong>AIDS</strong> advocated that care <strong>and</strong> <strong>support</strong><strong>for</strong> <strong>people</strong> <strong>living</strong> <strong>with</strong> <strong>HIV</strong> or <strong>AIDS</strong> should be comprehensive – embracing thepsychological/spiritual, social <strong>and</strong> medical dimensions – <strong>and</strong> integrated, <strong>with</strong> thevarious providers offering a “continuum of care” centred on the clients’ needs.This vision remains relevant today. As discussed earlier (see page 85), <strong>people</strong> <strong>with</strong><strong>HIV</strong> infection need a range of measures to <strong>support</strong> them (<strong>and</strong> their families) in coping<strong>with</strong> their situation <strong>and</strong> to enable them to live healthy, productive lives <strong>for</strong> as longas possible. Counsellors, religious communities <strong>and</strong> family members should providevital care <strong>and</strong> <strong>support</strong> at home <strong>and</strong> in the community. For diagnosis <strong>and</strong> therapy,patients <strong>and</strong> their carers must in turn be able to rely on the <strong>support</strong> of health services,such as home <strong>and</strong> community care programmes, private practitioners, localhealth centres, <strong>and</strong> clinics <strong>and</strong> hospitals.91
Report on the global <strong>HIV</strong>/<strong>AIDS</strong> epidemic – June 2000Since this vision was <strong>for</strong>mulated, UN<strong>AIDS</strong> has identified new opportunities <strong>for</strong> prioritizingaction <strong>and</strong> accelerating progress. UN<strong>AIDS</strong> proposes to target action along fivestrategic axes. Two are dealt <strong>with</strong> elsewhere in this report, while the others are discussedin separate sections below:• creating political will <strong>and</strong> mobilizing resources (see pages 107-115)• increasing access to voluntary <strong>HIV</strong> counselling <strong>and</strong> testing: over <strong>and</strong> above thebenefits <strong>for</strong> prevention, discussed earlier (see page 78), individuals who learnthey have <strong>HIV</strong> can gain access to <strong>support</strong> at an earlier stage <strong>and</strong>, <strong>with</strong> new preventiveregimens, may live longer <strong>and</strong> healthier lives (see pages 105–106)• increasing access to psychosocial <strong>support</strong> <strong>and</strong> impact alleviation• improving health service delivery• increasing access to drugs of special interest to <strong>people</strong> <strong>living</strong> <strong>with</strong> <strong>HIV</strong> infection.When possible, it is best <strong>for</strong> countries to develop plans <strong>for</strong> care <strong>and</strong> <strong>support</strong> as partof their strategic planning on <strong>HIV</strong>/<strong>AIDS</strong>, whether at national or district level. Healthsystem re<strong>for</strong>m can offer an opportunity to look at the range of care <strong>and</strong> <strong>support</strong>needs in a comprehensive manner (see Box 17).Box 17. Health re<strong>for</strong>ms <strong>and</strong> <strong>HIV</strong>: experience from Phayao Province,northern Thail<strong>and</strong>The Phayao Health Office undertook a review of its ef<strong>for</strong>ts to re<strong>for</strong>m the health sectorin the light of the lessons learnt from reducing the spread of <strong>HIV</strong> <strong>and</strong> caring <strong>for</strong><strong>people</strong> <strong>with</strong> <strong>AIDS</strong> in this badly affected province of the country. The Office posed anumber of questions to see whether the re<strong>for</strong>m was really improving the health sector’scapacity to tackle the epidemic effectively.Quality of life <strong>and</strong> autonomy are important concerns of <strong>people</strong> <strong>with</strong> <strong>HIV</strong> <strong>and</strong>their families.• Does the health re<strong>for</strong>m aim only to reduce rates of sickness <strong>and</strong> death?• Or is the re<strong>for</strong>m also geared to better quality of life, less dependence <strong>and</strong> greaterautonomy?People <strong>with</strong> <strong>HIV</strong> require comprehensive <strong>support</strong>, <strong>and</strong> not just medicines.• Does the health re<strong>for</strong>m aim mainly at better provision of health care?• Or does it also enable the health sector to catalyse community action <strong>and</strong> puthealth issues on the agenda of society <strong>and</strong> its decision-makers? –––>92